Stem Point Capital LP Protara Therapeutics, Inc. Transaction History
Stem Point Capital LP
- $340 Billion
- Q2 2024
A detailed history of Stem Point Capital LP transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 984,113 shares of TARA stock, worth $1.73 Million. This represents 0.6% of its overall portfolio holdings.
Number of Shares
984,113
Previous 87,900
1019.58%
Holding current value
$1.73 Million
Previous $13.2 Million
15424.88%
% of portfolio
0.6%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TARA
# of Institutions
43Shares Held
10.4MCall Options Held
25KPut Options Held
12.7K-
Opaleye Management Inc. Boston, MA2.3MShares$4.06 Million1.23% of portfolio
-
Ra Capital Management, L.P. Boston, MA1.9MShares$3.34 Million0.06% of portfolio
-
Boxer Capital, LLC San Diego, CA812KShares$1.43 Million0.09% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il665KShares$1.17 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY537KShares$944,8240.01% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $19.8M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...